Palo Alto Investors’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $16.1M | Sell |
1,113,045
-4,092,722
| -79% | -$58.7M | 2.46% | 14 |
|
|
2025
Q4 | $74.1M | Sell |
5,205,767
-162,031
| -3% | -$1.59M | 10.32% | 2 |
|
|
2025
Q3 | $42.3M | Sell |
5,367,798
-242,715
| -4% | -$1.73M | 7.83% | 4 |
|
|
2025
Q2 | $32.1M | Sell |
5,610,513
-1,734,489
| -24% | -$11.2M | 6.84% | 4 |
|
|
2025
Q1 | $59.9M | Sell |
7,345,002
-317,477
| -4% | -$2.94M | 11.41% | 3 |
|
|
2024
Q4 | $72.2M | Sell |
7,662,479
-482,832
| -6% | -$5.02M | 11.18% | 2 |
|
|
2024
Q3 | $87M | Sell |
8,145,311
-884,532
| -10% | -$9.63M | 11.3% | 2 |
|
|
2024
Q2 | $89.6M | Sell |
9,029,843
-314,259
| -3% | -$3.23M | 10.38% | 3 |
|
|
2024
Q1 | $110M | Sell |
9,344,102
-1,029,613
| -10% | -$13.2M | 12.41% | 2 |
|
|
2023
Q4 | $147M | Sell |
10,373,715
-150,307
| -1% | -$1.71M | 13.26% | 2 |
|
|
2023
Q3 | $128M | Hold |
10,524,022
| – | – | 12.11% | 4 |
|
|
2023
Q2 | $132M | Hold |
10,524,022
| – | – | 10.68% | 4 |
|
|
2023
Q1 | $117M | Buy |
10,524,022
+30,300
| +0.3% | +$373K | 9.67% | 4 |
|
|
2022
Q4 | $128M | Buy |
10,493,722
+645,948
| +7% | +$7.27M | 10.92% | 3 |
|
|
2022
Q3 | $103M | Hold |
9,847,774
| – | – | 8.13% | 6 |
|
|
2022
Q2 | $106M | Sell |
9,847,774
-55,987
| -0.6% | -$461K | 9.22% | 5 |
|
|
2022
Q1 | $93.8M | Sell |
9,903,761
-210,282
| -2% | -$1.97M | 7.25% | 5 |
|
|
2021
Q4 | $117M | Hold |
10,114,043
| – | – | 7.47% | 5 |
|
|
2021
Q3 | $96.6M | Buy |
10,114,043
+111,600
| +1% | +$1.14M | 5.83% | 8 |
|
|
2021
Q2 | $96.4M | Buy |
10,002,443
+241,400
| +2% | +$2.36M | 5.31% | 7 |
|
|
2021
Q1 | $96.4M | Buy |
9,761,043
+1,893,929
| +24% | +$29.3M | 5.49% | 6 |
|
|
2020
Q4 | $182M | Hold |
7,867,114
| – | – | 9.52% | 4 |
|
|
2020
Q3 | $111M | Buy |
7,867,114
+532,400
| +7% | +$7.76M | 6.1% | 6 |
|
|
2020
Q2 | $111M | Sell |
7,334,714
-112,904
| -2% | -$1.38M | 6.64% | 6 |
|
|
2020
Q1 | $68.8M | Buy |
7,447,618
+33,698
| +0.5% | +$320K | 5.76% | 10 |
|
|
2019
Q4 | $72.2M | Buy |
7,413,920
+251,000
| +4% | +$2.3M | 3.98% | 14 |
|
|
2019
Q3 | $57.4M | Sell |
7,162,920
-633,379
| -8% | -$6.87M | 3.83% | 13 |
|
|
2019
Q2 | $97.3M | Buy |
7,796,299
+176,466
| +2% | +$2.24M | 4.73% | 8 |
|
|
2019
Q1 | $104M | Buy |
7,619,833
+218,512
| +3% | +$2.67M | 4.32% | 10 |
|
|
2018
Q4 | $70.9M | Buy |
7,401,321
+1,035,174
| +16% | +$11.4M | 3.77% | 12 |
|
|
2018
Q3 | $77M | Buy |
6,366,147
+197,800
| +3% | +$2.77M | 3.11% | 13 |
|
|
2018
Q2 | $96.3M | Buy |
6,168,347
+20,518
| +0.3% | +$310K | 3.85% | 10 |
|
|
2018
Q1 | $92.5M | Buy |
6,147,829
+141,807
| +2% | +$2.16M | 3.95% | 9 |
|
|
2017
Q4 | $86.4M | Sell |
6,006,022
-1,414,266
| -19% | -$19.4M | 3.72% | 8 |
|
|
2017
Q3 | $112M | Sell |
7,420,288
-520,500
| -7% | -$6.89M | 4.71% | 8 |
|
|
2017
Q2 | $80M | Buy |
7,940,788
+57,800
| +0.7% | +$465K | 3.73% | 9 |
|
|
2017
Q1 | $56.2M | Buy |
7,882,988
+1,472,958
| +23% | +$9.31M | 2.66% | 14 |
|
|
2016
Q4 | $31.9M | Buy |
6,410,030
+724,642
| +13% | +$5.01M | 1.82% | 18 |
|
|
2016
Q3 | $42.1M | Buy |
5,685,388
+1,676,013
| +42% | +$11.3M | 2.44% | 14 |
|
|
2016
Q2 | $21.9M | Buy |
4,009,375
+458,202
| +13% | +$3.2M | 1.65% | 18 |
|
|
2016
Q1 | $30M | Hold |
3,551,173
| – | – | 2.33% | 11 |
|
|
2015
Q4 | $34.4M | Buy |
3,551,173
+1,576,797
| +80% | +$14.2M | 1.92% | 15 |
|
|
2015
Q3 | $27.6M | Hold |
1,974,376
| – | – | 1.33% | 16 |
|
|
2015
Q2 | $27.9M | Buy |
1,974,376
+18,000
| +0.9% | +$216K | 1.24% | 19 |
|
|
2015
Q1 | $21.3M | Hold |
1,956,376
| – | – | 1.05% | 24 |
|
|
2014
Q4 | $16.3M | Hold |
1,956,376
| – | – | 0.96% | 23 |
|
|
2014
Q3 | $11.6M | Sell |
1,956,376
-2,015,200
| -51% | -$10.6M | 0.87% | 27 |
|
|
2014
Q2 | $13.3M | Hold |
3,971,576
| – | – | 0.99% | 25 |
|
|
2014
Q1 | $8.22M | Sell |
3,971,576
-37,000
| -0.9% | -$92.5K | 0.68% | 26 |
|
|
2013
Q4 | $9.42M | Sell |
4,008,576
-613,654
| -13% | -$1.35M | 0.88% | 24 |
|
|
2013
Q3 | $10.7M | Hold |
4,622,230
| – | – | 1.12% | 20 |
|
|
2013
Q2 | $10.8M | Buy |
+4,622,230
| New | +$14.2M | 1.27% | 18 |
|
Other funds holding FOLD
VCM
PCM
VPM
GCL
Palo Alto Investors's FOLD Position: Q1 2026 in Review
Palo Alto Investors reduced its Amicus Therapeutics (FOLD) stake by 79% in Q1 2026, selling an estimated $58.7M and leaving 1,113,045 shares worth $16.1M. The position accounts for 2.46% of the portfolio, ranked #14.
Palo Alto Investors first reported a position in FOLD in Q2 2013 and has held it in 52 quarters since. The position peaked at $182M in Q4 2020. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.
- Palo Alto Investors held 1,113,045 shares of Amicus Therapeutics worth $16.1M as of Q1 2026.
- Palo Alto Investors sold 4,092,722 Amicus Therapeutics shares in Q1 2026, an estimated $58.7M.
- Amicus Therapeutics made up 2.46% of Palo Alto Investors's portfolio in Q1 2026, its #14 holding.
- Palo Alto Investors first reported a position in Amicus Therapeutics in Q2 2013 and has held it in 52 quarters since.
- Palo Alto Investors's Amicus Therapeutics position peaked at $182M in Q4 2020.
- 298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.
Based on Palo Alto Investors's 13F filing for Q1 2026, filed 15 May 2026.